CALC vs MRNA · $22.5M cap vs rev $145.0M
CalciMedica, Inc. Common Stock (CALC) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
CalciMedica, Inc. Common Stock (CALC) is a biotechnology company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
CALC does not have a complete income-statement cache yet.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
CALC currently screens at market cap $22.5M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the CALC and MRNA stock pages for the full models.
Not investment advice.